全球胰岛素笔市场（2023-2030）：规模、份额、成长分析与预测（按类型（第一代笔、第二代笔）、用途（预充式笔、可重复使用笔）

胰岛素笔市场规模预计将从2021年的10.9亿美元成长到2022年的11.6亿美元，预测期内年复合成长率为6.26%，到2030年将达到18.8亿美元。

近年来，由于糖尿病盛行率的增加以及胰岛素笔作为一种方便且用户友好的胰岛素输送方法的日益普及，全球胰岛素笔市场呈现显着增长。胰岛素笔具有使用方便、给药准确、便携等优点，成为糖尿病患者的首选。这个市场的推动因素是全球糖尿病人口不断增加，以及人们对胰岛素笔在糖尿病管理中的益处的认识不断增强，尤其是在新兴国家。此外，技术的进步促进了创新胰岛素笔的开发，其具有记忆功能、蓝牙连接以及与资料追踪和分析数位平台的兼容性等功能。这些进步透过增加患者便利性和改善治疗结果来推动进一步成长。另一方面，儘管全球胰岛素笔市场呈现积极成长轨迹，但仍面临一些挑战。

有些人恐惧症针头或抗拒感自行注射，这可能会限制他们对胰岛素笔的接受和使用。对针头的焦虑和恐惧会导致依从性下降和对替代胰岛素给药方法的偏好降低。此外，胰岛素笔製造商必须遵守严格的法规要求和安全标准，以确保其设备的品质、安全性和有效性。遵守法规和品管措施会增加製造流程的复杂性和成本。

本报告调查了全球胰岛素笔市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及各个细分市场和地区的细分。竞争形势、主要企业概况等

目录

• 执行摘要
• 调查方法
• 母市场分析
  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
• 关键市场洞察
  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 重点投资分析
  • 关键成功因素
  • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
  • 法规状况
  • 波特的分析
  • Skyquest 对未来颠覆的独家见解
• 全球胰岛素笔市场：按类型
  • 市场概况
  • 第一代笔
  • 第二代笔
• 全球胰岛素笔市场：依用途
  • 市场概况
  • 预填笔
  • 可重复使用的笔
• 全球胰岛素笔市场：按地区
  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲
• 竞争形势
  • 前5名企业对比
  • 主要企业市场地位
  • 主要企业的招募策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率
• 主要企业简介
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Ypsomed Holding AG
  • BD (Becton, Dickinson and Company)
  • Owen Mumford Ltd
  • Haselmeier AG
  • Medtronic plc
  • Companion Medical, Inc.
  • Biocon Ltd
  • Emperra GmbH E-Health Technologies
  • Bigfoot Biomedical, Inc.
  • Diamesco Co., Ltd.
  • MANNKind Corporation
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Pendiq GmbH
  • Sensile Medical AG
  • Injex Pharma AG
  • Copernicus Sp. z oo
  • Wockhardt Ltd

Insulin Pens Market size was valued at USD 1.09 Billion in 2021 and is poised to grow from USD 1.16 Billion in 2022 to USD 1.88 Billion by 2030, at a CAGR of 6.26% during the forecast period (2023-2030).

The global insulin pens market has witnessed significant growth in recent years due to the increasing prevalence of diabetes and the growing adoption of insulin pens as a convenient and user-friendly method of insulin delivery. Insulin pens offer advantages such as ease of use, accurate dosing, and portability, making them a preferred choice for diabetic patients. The market is driven by the rising diabetic population worldwide, especially in developing countries, coupled with the growing awareness about the benefits of insulin pens in managing diabetes. Furthermore, technological advancements have led to the development of innovative insulin pens with features like memory function, Bluetooth connectivity, and compatibility with digital platforms for data tracking and analysis. These advancements have enhanced patient convenience and improved treatment outcomes, thereby driving market growth. Despite the positive growth trajectory, the global insulin pens market faces certain challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Insulin Pens Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Pens Market Segmental Analysis

The global insulin pens market is segmented on the basis of type, usability, and region. By type, the market is segmented into first generation pens and second-generation pens. By usability, the market is segmented into prefilled pens and reusable pens. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Insulin Pens Market Dynamics

Insulin Pens Market Drivers

Technological Advancements

• Continuous technological advancements in insulin pen devices, such as Bluetooth connectivity, memory functions, and smart insulin pens, enhance patient experience and improve treatment outcomes. These advancements drive market growth by offering additional features and functionalities to users.

Preference for Self-Administration

• Insulin pens allow patients to self-administer insulin, reducing the need for healthcare provider assistance and promoting patient independence in managing their diabetes. The preference for self-administration contributes to the increasing adoption of insulin pens.

Insulin Pens Market Restraints

Needle Phobia and Resistance

• Some individuals may have needle phobia or resistance to self-injection, which can limit the acceptance and use of insulin pens. Needle anxiety or fear of injections may result in reduced compliance and preference for alternative insulin delivery methods.

Regulatory and Safety Considerations

• Insulin pen manufacturers need to comply with strict regulatory requirements and safety standards to ensure the quality, safety, and effectiveness of their devices. Compliance with regulations and quality control measures can add complexity and cost to the manufacturing process.

Market Trends of the Global Insulin Pens Key

• Customization and Personalization: There is a growing demand for insulin pens that cater to individual patient needs and preferences. Manufacturers are offering customizable options such as different color choices, dose settings, and even personalized branding. Customizable insulin pens enhance user engagement and satisfaction.
• Focus on Safety Features: Safety is a crucial aspect of insulin pens, and manufacturers are incorporating various safety features to ensure accurate dosing and minimize the risk of medication errors. Needle safety systems, dose confirmation mechanisms, and audible/visual alerts are among the safety features being introduced in insulin pen devices.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Insulin Pens Market by Type
  • Market Overview
  • first generation pens and second-generation pens
• Global Insulin Pens Market by Usability
  • Market Overview
  • prefilled pens and reusable pens
• Global Insulin Pens Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Novo Nordisk A/S - Denmark
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Eli Lilly and Company - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sanofi - France
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ypsomed Holding AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • BD (Becton, Dickinson and Company) - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Owen Mumford Ltd - UK
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Haselmeier AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medtronic plc - Ireland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Companion Medical, Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Biocon Ltd - India
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Emperra GmbH E-Health Technologies - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bigfoot Biomedical, Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Diamesco Co., Ltd. - South Korea
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • MANNKind Corporation - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Jiangsu Delfu Medical Device Co., Ltd. - China
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pendiq GmbH - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sensile Medical AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Injex Pharma AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Copernicus Sp. z o.o. - Poland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Wockhardt Ltd - India
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments